Precursor Condition
High Grade Squamous Intraepithelial Neoplasia
CI-CAN-00002885HSILExplore in graph →
Precursor10 active trials
- NCIt
- C8336
Loading cancer entity…
Precursor Condition
CI-CAN-00002885HSILExplore in graph →
Clinical trials
54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06949800 | CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial | recruiting | Phase 2 | 90 | University of California, San FranciscoOTHER | 2 | Sep 15, 2026 | clinicaltrials |
| NCT04712851 | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia | recruiting | Phase 2 | 25 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06075264 |
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)(ART-VIN IIB) |
| recruiting |
| Phase 2 |
| 27 |
| Frantz Viral Therapeutics, LLCINDUSTRY |
| 1 |
| Aug 14, 2025 |
| clinicaltrials |
Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials